Table 2.

Female Sexual Function Index (FSFI) and Female Sexual Distress Scale (FSDS) scores of women affected by endometriosis-associated pelvic pain during treatment with Dienogest 2 mg/die: long term management

FSFI domains	Baseline (n=54)	3 months (n=51)	6 months (n=49)	12 months (n=47)	18 months (n=43)	24 months (n=43)
Desire	3.4±1.3	3.1±1.2*	3.8±1.1*	4.1±1.2**	4.4±1.1**	4.5±1.2**
Arousal	4.1±1.1	4.1±1.2*	4.6±1.2**	4.9±1.2**	4.9±1.6**	5.1±1.2**
Lubrication	4.1±1.2	4.2±1.1*	4.5±1.3*	4.6±1.3**	4.9±1.3**	4.7±1.3**
Orgasm	3.9±1.1	4.1±1.3*	4.8±1.2**	5.1±1.3**	5.1±1.2**	5.2±1.3**
Satisfaction	3.8±1.1	4.1±1.4*	4.6±1.1**	5.3±1.2**	5.3±1.1**	5.2±1.2**
Dyspareunia	3.1±1.2	4.7±1.2**	5.5±1.3**	5.7±1.1**	5.6±1.2**	5.5±1.1**
FSFI score	22.3±1.3	23.9±1.3*	27.8±1.3**	29.7±1.4**	30.2±1.3**	30.3±1.7**
FSDS score	18.4±1.3	17.5±1.8*	11.3±1.4***	10.1±1.6***	10.3±1.7***	9.8±1.5***

Notes: Values are expressed as means ± SD. *Vs Baseline, p=NS. **Vs Baseline, p<0.001 (by non parametric Wilcoxon’ s rank sum test). ***Vs Baseline, p<0.001 (by Paired Student’s t -test).

Abbreviation: NS, not significant.